San Diego, California, United States Related Funds
| Fund Name | Location |
| Acatis Investment GMBH | Frankfort, Maine, United States |
| Amber Group | China, Hong Kong, Hong Kong Island |
| Angel Syndicates Central | Alabama, Huntsville, United States |
| Bank of Beijing | Beijing, Beijing, China |
| BitFury Capital | Amsterdam, Noord-Holland, The Netherlands |
| Centurium Capital | Beijing, Beijing, China |
| Crimson Peak | - |
| Fermata | Japan, Meguro |
| HBM-MedFocus | - |
| Holta Invest | Norway, Oslo |
| J. Hunt Holdings | United States, Vienna, Virginia |
| Leopard Capital | Cambodia, Phnom Penh |
| NewLake Capital Partners | Chicago, Illinois, United States |
| Scala | Malvern, Pennsylvania, United States |
| Spinner Global Technology Fund | - |
| Startup Canada | Canada, Ontario, Ottawa |
| Sulphur Creek Ventures | California, St. Helena, United States |
| The Next Women | Amsterdam, Noord-Holland, The Netherlands |
| Wenshi Touzi | China, Shanghai |
| Yoma Strategic Holdings | Central Region, Singapore, Singapore |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Aardvark Therapeutics | $29M | 05 Aug 2021 | San Diego, California, United States | ||
Globavir | $4M | 31 Jan 2015 | California, United States |
– Aardvark Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on developing and commercializing novel small molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases.
– The company completed a $29m Series B financing.
– The round was led by Sorrento Therapeutics with participation from existing investors including Vickers Venture Partners, Premier Partners, BNH Investment, and Korea Omega.
– The funds raised will be deployed to advance the company’s pipeline of programs for metabolic diseases.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Aardvark Therapeutics | $29M | 05 Aug 2021 | San Diego, California, United States | ||
Globavir | $4M | 31 Jan 2015 | California, United States |
